Classification of Lymphoma, Benign Lesions, and Carcinoma Using Convolutional Neural Network
- DOI
- 10.2991/978-94-6463-062-6_18How to use a DOI?
- Keywords
- CNN; MobileNet; Inception; VGG16
- Abstract
Lymphoma, carcinoma, and benign lesions are common diseases that have to go through several stages to be detected due to their structural similarity. A common way to distinguish these diseases is by analysing them manually based on the cell images at a certain magnification. However, this method still has many shortcomings in terms of accuracy as it is vulnerable to possible human error and requires quite a lot of time. Thus, an alternative faster and more accurate method of detection should be developed to increase patients’ chances of survival. One solution to overcome this problem is by using a deep learning model which mimics the behaviour of nerve cells in the human brain and has proven to be able to classify certain diseases in many studies. As there are many existing deep learning designs, this paper aims to explore the methods of detecting these diseases and find the best performance (highest accuracy) among them. With the microscope images data (magnifications of 100 and 400 times) provided by the medical faculty of the University of Padjadjaran (UNPAD), we investigated the classification result using different kinds of deep learning designs which were our designed CNNs and transfer learning using the Inception-V3, VGG16, and MobileNet. It was found that the best model used to classify images with a magnification of 100x is MobileNet (accuracy of 53% for benign lesions and 47% for lymphoma) and designed CNN (accuracy of 59% for benign lesions and 41% for lymphoma). While for image classification with a magnification of 400x, Inception-V3 showed the best result (accuracy of 80% for carcinoma and 50% for lymphoma).
- Copyright
- © 2023 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Hanina Nuralifa Zahra AU - Isa Anshori AU - Hasna Nadila AU - Hofifa Mulya Utami AU - Joshua Adi Chandra AU - Muhammad Rashid Kurniawan AU - Yunianti Khotimah AU - Widyawardana Adiprawita AU - Hermin Aminah Usman AU - Okky Husain PY - 2022 DA - 2022/12/22 TI - Classification of Lymphoma, Benign Lesions, and Carcinoma Using Convolutional Neural Network BT - Proceedings of the 4th International Conference on Life Sciences and Biotechnology (ICOLIB 2021) PB - Atlantis Press SP - 175 EP - 192 SN - 2468-5747 UR - https://doi.org/10.2991/978-94-6463-062-6_18 DO - 10.2991/978-94-6463-062-6_18 ID - Zahra2022 ER -